Senior insider sale
SVP, General Counsel at FULCRUM THERAPEUTICS, INC. — senior position signals high conviction
$44.9K
3.45K shares
What this filing means
OLTMANS CURTIS GALE plans to sell 3.45K shares of FULCRUM THERAPEUTICS, INC. valued at approximately $44.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/15/2025ACC: 0001950047-25-010350
Officer· SVP, General Counsel
Since Nov 2020
3.45K
Shares to sell
$44.9K
Approx. market value
3.45K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Employee Stock Purchase Plan
Cash
11/12/2021
3.45KTotal acquired3.45K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/12/2021 | Employee Stock Purchase Plan Cash | 3.45K | — |
| Total | 3.45K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.45K
Market value
$44.9K
12/15/2025
Total
Units
3.45K
Value
$44.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/15/2025 | 3.45K | $44.9K | NASDAQ | Planned |
| Total | 3.45K | $44.9K | ||